GLOBUS MEDICAL, INC. Cost of Goods Sold (Deprecated 2018-01-31)
GLOBUS MEDICAL, INC. (GMED) reported Cost of Goods Sold (Deprecated 2018-01-31) of $37.97 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-05-03
- GLOBUS MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $37.97M, a 6.66% increase year-over-year.
- GLOBUS MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $40.86M, a 4.75% increase year-over-year.
- GLOBUS MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $36.80M, a 16.99% increase year-over-year.
- GLOBUS MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $37.20M, a 13.65% increase year-over-year.
- GLOBUS MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $150.45M, a 11.69% increase from fiscal 2016.
- GLOBUS MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $134.71M, a 1.79% increase from fiscal 2015.
- GLOBUS MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $132.33M, a 19.47% increase from fiscal 2014.
- GLOBUS MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $110.77M, a 10.39% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $37.97M 10-Q · filed 2018-05-03 | $78.83M derived: sum of 2 quarters · filed 2018-05-03 | $115.62M derived: sum of 3 quarters · filed 2018-05-03 | $152.82M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-12-31 | $40.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $77.65M derived: sum of 2 quarters · filed 2018-02-22 | $114.85M derived: sum of 3 quarters · filed 2018-02-22 | $150.45M 10-K · filed 2018-02-22 | ||||
| 2017-09-30 | $36.80M 10-Q · filed 2017-11-09 | $74.00M derived: sum of 2 quarters · filed 2017-11-09 | $109.60M 10-Q · filed 2017-11-09 | $148.60M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-06-30 | $37.20M 10-Q · filed 2017-08-03 | $72.80M 10-Q · filed 2017-08-03 | $111.80M derived: sum of 3 quarters · filed 2018-05-03 | $143.25M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-03-31 | $35.60M 10-Q · filed 2018-05-03 | $74.60M derived: sum of 2 quarters · filed 2018-05-03 | $106.06M derived: sum of 3 quarters · filed 2018-05-03 | $138.79M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | $39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $70.45M derived: sum of 2 quarters · filed 2018-02-22 | $103.19M derived: sum of 3 quarters · filed 2018-02-22 | $134.71M 10-K · filed 2018-02-22 | ||||
| 2016-09-30 | $31.45M 10-Q · filed 2017-11-09 | $64.18M derived: sum of 2 quarters · filed 2017-11-09 | $95.70M 10-Q · filed 2017-11-09 | $130.64M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $32.73M 10-Q · filed 2017-08-03 | $32.86M 10-Q · filed 2016-07-27 | $64.25M 10-Q · filed 2017-08-03 | $64.50M 10-Q · filed 2016-07-27 | $99.19M derived: sum of 3 quarters · filed 2018-02-22 | $132.12M derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-03-31 | $31.52M 10-Q · filed 2017-05-04 | $31.64M 10-Q · filed 2016-05-04 | $66.46M derived: sum of 2 quarters · filed 2018-02-22 | $99.39M derived: sum of 3 quarters · filed 2018-02-22 | $131.97M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $34.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $67.87M derived: sum of 2 quarters · filed 2018-02-22 | $100.45M derived: sum of 3 quarters · filed 2018-02-22 | $132.33M 10-K · filed 2018-02-22 | $132.80M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $32.93M 10-Q · filed 2016-11-09 | $33.05M 10-Q · filed 2015-11-04 | $65.51M derived: sum of 2 quarters · filed 2016-11-09 | $97.39M 10-Q · filed 2016-11-09 | $97.74M 10-Q · filed 2015-11-04 | $128.80M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $32.58M 10-Q · filed 2016-07-27 | $64.69M 10-Q · filed 2016-07-27 | $95.87M derived: sum of 3 quarters · filed 2017-03-16 | $123.56M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $32.11M 10-Q · filed 2016-05-04 | $63.30M derived: sum of 2 quarters · filed 2017-03-16 | $90.98M derived: sum of 3 quarters · filed 2017-03-16 | $117.56M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $31.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $58.87M derived: sum of 2 quarters · filed 2017-03-16 | $85.46M derived: sum of 3 quarters · filed 2017-03-16 | $110.77M 10-K · filed 2017-03-16 | $110.86M 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $27.69M 10-Q · filed 2015-11-04 | $54.27M derived: sum of 2 quarters · filed 2015-11-04 | $79.58M 10-Q · filed 2015-11-04 | $107.61M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $26.58M 10-Q · filed 2015-07-31 | $51.90M 10-Q · filed 2015-07-31 | $79.93M derived: sum of 3 quarters · filed 2016-02-29 | $105.24M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $25.31M 10-Q · filed 2015-05-05 | $53.35M derived: sum of 2 quarters · filed 2016-02-29 | $78.66M derived: sum of 3 quarters · filed 2016-02-29 | $102.16M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $28.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $53.35M derived: sum of 2 quarters · filed 2016-02-29 | $76.85M derived: sum of 3 quarters · filed 2016-02-29 | $100.34M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $25.32M 10-Q · filed 2014-10-31 | $48.82M derived: sum of 2 quarters · filed 2014-10-31 | $72.31M 10-Q · filed 2014-10-31 | $91.87M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $23.50M 10-Q · filed 2014-08-06 | $46.99M 10-Q · filed 2014-08-06 | $66.55M derived: sum of 3 quarters · filed 2015-02-26 | $85.42M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $23.49M 10-Q · filed 2014-04-30 | $43.05M derived: sum of 2 quarters · filed 2015-02-26 | $61.92M derived: sum of 3 quarters · filed 2015-02-26 | $80.30M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $19.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $38.43M derived: sum of 2 quarters · filed 2015-02-26 | $56.81M derived: sum of 3 quarters · filed 2015-02-26 | $75.20M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $18.87M 10-Q · filed 2013-10-31 | $37.25M derived: sum of 2 quarters · filed 2013-10-31 | $55.64M 10-Q · filed 2013-10-31 | $75.13M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $18.38M 10-Q · filed 2013-08-02 | $36.77M 10-Q · filed 2013-08-02 | $56.26M derived: sum of 3 quarters · filed 2014-03-14 | $73.40M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $18.39M 10-Q · filed 2013-05-03 | $37.88M derived: sum of 2 quarters · filed 2014-03-14 | $55.02M derived: sum of 3 quarters · filed 2014-03-14 | $72.29M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $19.49M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $36.63M derived: sum of 2 quarters · filed 2014-03-14 | $53.90M derived: sum of 3 quarters · filed 2014-03-14 | $68.80M 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $17.14M 10-Q · filed 2012-11-02 | $34.41M derived: sum of 2 quarters · filed 2012-11-02 | $49.31M 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $17.27M 10-Q/A · filed 2012-09-19 | $32.17M 10-Q/A · filed 2012-09-19 | ||||||
| 2010-12-31 | $53.83M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |